Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stereotactic Body Radiation Therapy for Inoperable Non-metastasized Pancreatic Adenocarcinoma: a Randomized Phase II Study

NCT06691425 is registered in ClinicalTrials.gov with Cancer Research Antwerp as lead sponsor.

NCT NCT06691425
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06691425 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stereotactic Body Radiation Therapy for Inoperable Non-metastasized Pancreatic Adenocarcinoma: a Randomized Phase II Study
Lead sponsor
Cancer Research Antwerp
Phase
Not applicable
Overall status
Recruiting
Start date
July 19, 2024
Completion date
July 31, 2030
Enrollment
160 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

non-metastasized unresectable pancreatic carcinoma